Accessibility Menu
Igene Biotechnology logo

Igene Biotechnology(OTC) IGNE

Market Cap$1.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1990)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Igene Biotechnology last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-16
Igene Biotechnology stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-06-04
1 month+0%USD 0.002026-06-04
3 month+0%USD 0.002026-03-24
Year to date+0%USD 0.002025-11-10
1 year+0%USD 0.002024-12-12
3 year+0%USD 0.002023-05-12
5 year-99.87%USD 0.002021-07-16
Since inception-100%USD 0.301990-10-25

Igene Biotechnology Financials at a Glance

Market Cap

$1.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$4.80K

Net Income (TTM)

-$2.37M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

4.54 (High)

Price

$0.00

Volume

1

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

IGNE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Igene Biotechnology

Igene Biotechnology, Inc. is focused on the discovery, development, production, and commercialization of specialized ingredients for human and animal nutrition. The company is known for its natural astaxanthin, a nutrient used as a coloring agent in aquaculture, particularly for farmed salmon and trout.

Products and Services
  • Natural astaxanthin for aquaculture and nutraceuticals
  • Research and development services for microbial strains
  • Analytical chemistry services for carotenoid identification
Growth Outlook
  • Expansion in the nutraceutical market is anticipated
  • Increasing demand for natural ingredients in aquaculture
  • Potential for new product development in animal feed
Financial Highlights
  • Recent quarterly revenue of $0, indicating ongoing challenges
  • Trailing twelve months (TTM) net income margin of -3.56%
  • Current ratio of 2.35, suggesting strong short-term liquidity
Igene Biotechnology, Inc. operates in the agricultural inputs sector, providing essential ingredients that cater to both human and animal nutrition markets. The company has established itself as a key player in the production of natural astaxanthin, which is increasingly sought after in aquaculture for its health benefits and coloring properties. Despite facing financial challenges, as evidenced by the recent quarterly revenue of $0, the company maintains a strong current ratio of 2.35, indicating a solid liquidity position. The growth outlook remains positive, driven by the rising demand for natural ingredients in both the nutraceutical and animal feed sectors. As the market continues to evolve, Igene's focus on research and development may lead to innovative product offerings, positioning the company for potential future growth.
AI Generated • Jul 23, 2026

Industry

Chemicals

Sector

Materials

Headquarters

Columbia, MD 21045, US

IGNE Financials

Key Financial Metrics (TTM)

Gross Margin

25.66%

Operating Margin

-27.03%

Net Income Margin

-3.56%

Return on Equity

5.19%

Return on Capital

-26.39%

Return on Assets

-2.96%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.57B

Volume

1

Avg. Volume

1.064

Financials (TTM)

Gross Profit

$40.85K

Operating Income

-$2.33M

EBITDA

-$457.78K

Operating Cash Flow

-$1.68M

Capital Expenditure

$16.62K

Free Cash Flow

-$1.67M

Cash & ST Invst.

$269.29K

Total Debt

$7.34M

Igene Biotechnology Performance Analysis

Igene Biotechnology sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42009-12-31-99.6%
Q12010-03-31-100.0%
Q22010-06-30N/A
Q32010-09-30N/A
Igene Biotechnology sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42009-12-31-300.0%
Q12010-03-31-100.0%
Q22010-06-30-25.0%
Q32010-09-3020.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2010YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$1.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$88.89

N/A

Employees

18

N/A

Net Income

-$627.24K

-646.3%

EBITDA

-$57.76K

-109.4%

Quarterly Fundamentals

Name
Q3 2010YOY CHG

Total Cash

$269.29K

-89.7%

Total Debt

$7.34M

-0.4%

Accounts Receivable

$2.17M

+16.7%

Inventory

$0.00

N/A

Long Term Debt

$5.72M

+0.7%

Short Term Debt

$1.61M

-4.1%

Return on Assets

-2.96%

N/A

Return on Invested Capital

-33.43%

N/A

Free Cash Flow

-$710.59K

-3.0%

Operating Cash Flow

-$710.59K

-3.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SLSDFSelect Sands Corp.
$0.00+0.00%
GRENGreensmart Corp
$0.00+0.00%
CBLRFCampbell Resources Inc.
$0.00+0.00%
AGYPAllied Energy Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$41.43-0.05%
NVDANvidia
$206.64+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.81+0.07%
INTCIntel
$91.00+0.01%

Questions About IGNE

What is the current price of Igene Biotechnology?

Igene Biotechnology is trading at $0.00 per share.

What is the 52-week range for Igene Biotechnology?

Over the past 52 weeks, Igene Biotechnology has traded between $0.00 and $0.00.

How much debt does Igene Biotechnology have?

Igene Biotechnology total debt is unavailable.

How much cash does Igene Biotechnology have on hand?

Igene Biotechnology does not have cash on hand data available.

What is Igene Biotechnology’s dividend yield?

Igene Biotechnology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.